Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Monoamine Oxidase
    (6)
  • Bcr-Abl
    (3)
  • NR4A
    (3)
  • AChR
    (2)
  • Beta Amyloid
    (2)
  • Dopamine Receptor
    (2)
  • LRRK2
    (2)
  • NOD-like Receptor (NLR)
    (2)
  • PPAR
    (2)
  • Others
    (22)
Filter
Search Result
Results for "

parkinson's diseases

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    62
    TargetMol | All_Pathways
  • Compound Libraries
    4
    TargetMol | Compound_Libraries
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
  • Natural Products
    11
    TargetMol | Natural_Products
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
PLX5622
PLX-5622
T71001303420-67-8
PLX5622 is an orally active small-molecule CSF1R inhibitor that selectively depletes microglia in the brains of mice and rats. It is commonly used to establish models related to microglia-associated neuroinflammation, neurodegenerative diseases (such as Alzheimer's disease and Parkinson's disease), brain injury, and neuroimmune regulation.
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited